![]() ![]() |
|
Home |
Online Catalog |
Newsletters |
Therapy Index |
Psoriasis / Eczema |
Free Vitamins |
Order |
Contact Us |
| Now it's Patented - There is a Cure for the Common Cold |
Purchase K897 Zinc Lozenges from Nutrimed.com
An Effective Zinc Lozenge
Even though weve been told all our lives that there is no cure for the common cold, Americans still spend about 5.5 billion dollars per year treating their colds...about $3 billion going to the doctor, about $1.5 billion on remedies and another $1 billion on analgesics. Over one billion common colds occur in the United States each year and about 5% of the population will have a cold at any given time. Colds are responsible for about 60 million lost days of school and 50 million lost days of work each year.(1) Common colds may be caused by over 200 types of viruses, with over 113 types of human rhinoviruses causing the majority of them. Cold symptoms can also be caused by corona, influenza, herpes simplex, respiratory syncytial, coxsackie, parainfluenza, adeno and echo viruses. With such a large number of different viruses that can cause cold symptoms, developing a cold vaccine would be virtually impossible.(2)
Zinc Lozenges Patented as a Cure However, just taking a zinc supplement will not cure a cold, and not all zinc lozenges are effective. Developing this patented formula took years of testing to determine which combinations worked and which did not. Chelating agents, flavorings, pH and even the compression force used in manufacturing can alter the effects of zinc lozenges.
Effective Use of Zinc for Colds It is important that the lozenges dissolve slowly to keep the Zn2+ ions in contact with oral tissues long enough to be diffused into the tissues. And for that reason, the lozenge needs to be pleasant-tasting.
Zn2+ Availability When highly chelated forms of zinc, such a orotate, aspartate, citrate and amino acid chelates have been used to improve taste and reduce aftertaste, these strong chelators prevented the release of positively charged zinc ions, making these products ineffective.(1,5, 6)
Effects of Zn2+ Ions
The most likely explanation for the rapid response to zinc lozenges is membrane stabilization and closing of membrane pores by Zn2+ ions. Pore closure applies to inflammation and mucus producing cells such as mast and goblet cells, and tissues dry quickly.
Discovered By a Three-Year-Old A British trial produced similar results. Were Original Trials Faulty? When the results of these trials were published, a number of companies began making and selling zinc lozenges for colds...but in further trials, findings were negative. The lozenges did not shorten the duration of colds and in some cases made them last a day or two longer.(l,6) What happened? Zinc gluconate has a chalky taste and an unpleasant aftertaste that may linger for as long as 24 hours. So manufacturers set out to make a better tasting lozenge...by reducing the amount of zinc, using highly chelated forms of zinc, adding sweeteners and flavorings to mask the taste, and adding vitamin C to make it work even better. These changes, designed to improve patient compliance, resulted in products that were ineffective.(1,6) Vitamin C may be taken separately for a cold, but when added to zinc lozenges, it changes the pH and acts as a strong chelator, making the zinc ions unavailable to oral tissues. Adding sweeteners didn't improve patient compliance either. All sweeteners, with the exception of fructose, react with zinc gluconate over a period of weeks and the taste becomes incredibly bitter. Although fructose doesnt cause bitterness, it doesnt help much. It turns chalky tasting lozenges with a lingering aftertaste into sweet chalky tasting lozenges with a lingering aftertaste. So it seemed that zinc lozenges could either be effective or they could taste good...not both. Most people just decided that the original studies must have been faulty and zinc lozenges didnt really work, but George Eby and others continued their research. Many other compounds were tried. Those that were highly stable had no effect on colds. Unstable compounds such as zinc gluconate or chloride reacted with their sweeteners and taste bitter. Zinc Acetate Solves the Problem The taste/availability problem was solved with zinc acetate. Zinc acetate does not have the unpleasant taste or offensive lingering aftertaste associated with other highly ionizable zinc compounds. Pleasant tasting zinc acetate lozenges made with sucrose, fructose or dextrose remain flavor-stable for many years when stored in sealed containers. When additional flavoring is used, natural peppermint oil is suggested.(1) The benefits of zinc acetate go beyond pleasant taste. For example, zinc acetate dihydrate is 29.78% zinc, compared to 13.14% zinc in zinc gluconate and is 3.33 times as ionizable as zinc gluconate at physiologic pH 7.4. With zinc acetate, 100% of the zinc is available as Zn2+ ions. No neutrally charged ions are released.(1) Only compounds such as zinc acetate that release 100% of their zinc at pH 7.4 as Zn2+ ions are believed to be completely non-cytotoxic. Since the positively charged zinc ions decrease cell membrane permeability, additional zinc is not absorbed into the cells and zinc serum levels do not rise.
At the First Sign of a Cold Dosage is generally one or two lozenges (one at a time...not two at the same time) every hour to two hours while awake and at bedtime until symptoms are gone. Lozenges should be used after eating or drinking rather than before so that the zinc will not be washed away and it is important to let the lozenges dissolve slowly...don't chew them up. REFERENCES
l. Eby, George A., Handbook for Curing the Common Cold -- The Zinc Lozenge Story, George Eby Research, Austin, TX, 1994.
2. Castleman, M, Cold Cures, Fawcett Columbine, New York, 1987. 3. Bryce-Smith, D., Spray preparations for respiratory tract infections, European Patent Application 381522, August 8, 1990. 4. Eby, George A., Davis, D.R., Halcomb, W.W., Reduction in duration of common colds by zinc gluconate lozenges in a double blind study, Antimicrobial Agents and Chemotherapy. 1984;25:20-24. 5. Eby, George A., Davis, D.R., Halcomb, W.W., Effect of zinc orotate lozenges with zinc gluconate nasal spray in common cold treatment -- a double blind study, Unpublished Data, 1984 6. Zarembo, John E., et. al, Zinc (II) in Saliva: Determination of Concentrations Produced by Different Formulations of Zinc Gluconate Lozenges Containing Common Excipients, Journal of Pharmaceutical Sciences, Feb., 1992;81(2):128-130. |
|
Home | Online Catalog | Newsletters | Therapy Index | Psoriasis / Eczema | Free Vitamins | Order | Contact Us Copyright © 1996-2007 Nutrimed Labs, Inc. |